MeSH tree: D02.455.426.392.368.242
Natural health products and phytomedicines (plant-based medicines) are used in many countries as the first choice of treatment. This market represents a significant proportion of the total market for health products, particularly ...
Jul 27, 2023
0
24
A new, biodegradable ultrasound far more powerful than previous devices could make brain cancers more treatable, University of Connecticut researchers report in the June 14 issue of Science Advances.
Jun 14, 2023
0
132
A new research paper was published in Oncotarget, titled "Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)."
Jun 7, 2023
0
42
Chemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer—the taxanes ...
Jun 1, 2023
0
83
A new editorial paper was published in Oncoscience, titled, "UPR-induced ovarian cancer cell fusion: a mechanism favoring drug resistance?"
May 26, 2023
0
81
Autologous conditioned serum (ACS)—a biologic therapy that famous athletes swear by to treat arthritis and sports injuries—also shows benefit for the kind of neurological pain caused by chemotherapy or diabetes.
May 23, 2023
0
76
A major impediment to treating the deadly brain cancer glioblastoma has been that the most potent chemotherapy can't permeate the blood-brain barrier to reach the aggressive brain tumor.
May 2, 2023
0
115
Researchers at Johns Hopkins University School of Medicine say they have evidence from a new study in rats that spinal cord stimulation (SCS) may be useful in reducing chronic pain in people undergoing active treatment with ...
Apr 27, 2023
0
27
Medication delivered by a novel gel cured 100% of mice with an aggressive brain cancer, a striking result that offers new hope for patients diagnosed with glioblastoma, one of the deadliest and most common brain tumors in ...
Apr 24, 2023
0
93
For patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen deprivation therapy (ADT), and doublet therapy ...
Apr 12, 2023
0
47
